Clinical Trial Update: SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes [Phase 3]

View source ↗

Summary

Phase 3 of the SeMaglutide and Albuminuria Reduction trial in obese individuals without diabetes has completed. The study is sponsored by University Medical Cen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Obesity, Albuminuria | Phase 3 | Status: COMPLETED